Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Immuneering (IMRX) Return on Equity (2021 - 2026)

Immuneering's Return on Equity history spans 6 years, with the latest figure at 0.0% for Q1 2026.

  • On a quarterly basis, Return on Equity rose 1.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 1.0% increase, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity came in at 0.0% for Q1 2026, down from 0.0% in the prior quarter.
  • The five-year high for Return on Equity was 0.0% in Q4 2025, with the low at 0.02% in Q2 2025.
  • Historically, Return on Equity has averaged 0.01% across 5 years, with a median of 0.0% in 2023.
  • Biggest five-year swings in Return on Equity: decreased -1bps in 2022 and later rose 1bps in 2025.
  • Year by year, Return on Equity stood at 0.0% in 2022, then decreased by -29bps to 0.01% in 2023, then crashed by -120bps to 0.01% in 2024, then soared by 80bps to 0.0% in 2025, then fell by -3bps to 0.0% in 2026.
  • Business Quant data shows Return on Equity for IMRX at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.